Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Advanced Life Science Institute, Inc. is a Japanese company located in Tokyo that manufactures and wholesales testing drugs of hepatitis viruses and lung cancers. It was founded in 1997.

Engages in priniting activities

Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. The Company's research and development focus is on the treatment of hepatitis C virus (HCV). In July 2009, the Company completed the proof-of-concept clinical trial in treatment-naive HCV genotype I infected patients. In October 2009, it initiated a 14-day dose-ranging phase IIa clinical trial evaluating IDX184 in combination with pegylated interferon and ribavirin in treatment-naive HCV genotype I infected patients. Idenix selected IDX320 as its lead clinical candidate from its protease inhibitor discovery program. The Company has also developed products and drug candidates for the treatment of hepatitis B virus (HBV), human immunodeficiency virus type I (HIV) and acquired immune deficiency syndrome (AIDS).

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Xiamen Innovax Biotech Co., Ltd. manufactures vaccines and diagnostic reagents. It focuses on research and development, manufacturing, marketing of vaccine, diagnosis kit and medical equipment. The company was founded in 2005 and is headquartered in Xiamen, China.

Meide (Jiangxi) Biotechnology Co., Ltd., established on 2003-11-24, Business scope includes licensed projects:food business,Grain Purchase,road freight transport(Does not contain dangerous goods),Main crop seed production,Processing of Agricultural GMO Products,feed production,Forest tree seed production and management,Genetically Modified Cotton Seed Management,rice drying(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Medical Research and Experimental Development,Grain and oil storage service,grain sales,Bean and potato sales,Retailing of Edible Agricultural Products,Sales of agricultural and sideline products,Primary processing of edible agricultural products,General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval),Crop Cultivation Services,Non-Major Crop Seed Production,grain planting,cotton planting,vegetable planting,Feed Raw Material Sales,Non-residential real estate leases,Land use right lease(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Yangshengtang Co., Ltd. engages in the management of pharmaceutical and food products. Its business activities include road cargo transportation, catering services, product packaging design, real estate development, housing rental services, business management consulting, and marketing planning services. It sells cosmetics, clothing, furniture, paper, office equipment, electronic products, communication equipment, agricultural and fishery products, and chemical products. The company was founded on March 12, 1993 and is headquartered in Hangzhou, China.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Part of ApicHope Pharmaceutical Co., Ltd., Guangzhou Yipinhong Pharmaceutical Co., Ltd. is a Chinese company located in Guangzhou that manufactures pharmaceutical products. The firm was founded in 2010.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Nanjing Yiyuan Biomedical Research Institute Co., Ltd., established on 2018-07-05, Business scope includes biomedical research and experimental development(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology);Engineering and Technology Research and Experimental Development;Technical extension services;Technology intermediary service;medicine,Nutrition and Health Food,Special chemical products and daily chemical products,Pharmaceutical and medical equipment sales;Trade Brokers & Agents.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guoqing Biomedicine (Shanghai) Co., Ltd., established on 2019-03-29, Business scope includes biomedical technology(remove human stem cells,Genetic diagnosis and treatment development and application technology)technology development in the field,technical consulting,Technical Services,technology transfer,Medical device management,Drug Wholesale,Veterinary drug business,New material technology promotion service,Health Advisory,Home remote health management service,Community telehealth management service,Comprehensive Management Services,Trade Brokers & Agents. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.